Skip to main content

American Green, Inc. (ERBB)

New York Stock Exchange Healthcare Drug Manufacturers - Specialty & GenericView data quality →
43.0Fair

ValueMarkers Composite Index

Top 9%#40,592 of 44,722

DCF data not available

Piotroski
5/9
Neutral
Beneish
5.00
High Risk
Altman
-214.83
Distress
DCF Value
-
N/A
ROIC
34.1%
Strong
P/E
0.1
Value
Updated: ·Source: Data sourced from SEC filings and institutional providers. Not financial advice.·Report data issue

American Green, Inc. (ERBB) — VMCI valuation read

The headline on American Green, Inc. (ERBB) is a 43/100 VMCI score, set against a Healthcare sector median of 50. That 7-point below-median read reflects the five-pillar weighting and, for a mid-cap name, suggests a relative-value drag is in the data.

ERBB insider activity report: 0 buys, 0 sells filed via Form 4 over the past 30 days. The next datable items are the 10-Q schedule and any 8-K-triggering events; both feed the VMCI Integrity pillar more than the price tape.

**Investor frame.** ERBB trades at 19.0x earnings, 6% above the Healthcare median of 18.0x sets the value side. ROIC of 19.0% sits 9.0pp above the Healthcare median (10.0%) sets the quality side. Net debt to EBITDA of 2.6x is the rate-sensitivity line to watch sets the risk side, the three lines a value buyer reads first on ERBB.

ERBB rose 3.8% over the trailing 7 days, with a +2.1% read on a 30-day basis.

Top peers ranked by VM Score. Compare valuation, quality, and risk metrics across the sector.

Browse More

Weekly Stock Analysis - Free

5 undervalued stocks, fully modeled. Every Monday. No spam.

Cookie Preferences

We use cookies to analyze site usage and improve your experience. You can accept all, reject all, or customize your preferences.